be rescued, whereas virus lacking ORF4 was replication-competent. ORF4-deficient NYMV 30 readily established a persisting non-cytolytic infection but failed to produce infectious viral 31 particles, supporting the view that ORF4 represents an essential factor for NYMV particle 32 assembly. 33
34

MAIN TEXT 35
Nyamanini virus (NYMV) is the prototype member of a novel genus in the order 36
Mononegavirales, designated "Nyavirus" (11). Recently, Kuhn and coworkers (7) proposed 37 classifying NYMV as a member of a new mononegaviral family, designated "Nyamiviridae". 38 NYMV replicates in the nucleus of infected cells (5), and viral budding was proposed to occur 39 at the plasma membrane (11). The NYMV genome contains six major open reading frames 40 (ORF). The viral nucleoprotein N, the glycoprotein G and the polymerase L are encoded by 41 ORF1, ORF5 and ORF6, respectively. We recently showed that ORF3 codes for a polymerase 42 cofactor which is required for NYMV polymerase activity (5). The functions of the proteins 43 encoded by ORF2 and ORF4 remain largely unknown. ORF2 negatively regulates NYMV 44 polymerase activity, presumably through interaction with the ORF3 product (5). ORF2 was 45 further shown to promote production of infectious virus-like particles by an unknown 46 mechanism (5). Formation of virus-like particles required the simultaneous presence of the 47 viral G protein, the product of ORF4 and the product of ORF2, indicating that ORF2 and 48 ORF4 both play a role in NYMV particle assembly (5). It remains unclear, however, whether 49 ORF4 represents the NYMV-specific equivalent of a matrix protein typically found in 50 negative-strand RNA viruses. No substantial homology was detected between ORF4 of 51 NYMV and matrix proteins of other members of the order Mononegavirales (11). 52
Matrix (M) proteins of negative-strand RNA viruses orchestrate the assembly of viral 53 particles by binding to both, the viral ribonucleoprotein (RNP) complex and cellular 54 membranes (reviewed in (3) and (8)). The importance of M proteins for the assembly and 55 budding of negative-strand RNA viruses was directly demonstrated for rabies virus, measles 56 virus and Sendai virus by employing reverse genetics approaches (2, 6, 10). M-deficient 57 variants of these viruses showed extensive cell-to-cell spreading but failed to produce cell-58 free infectious particles. 59
To further characterize the ORF2 and ORF4 genes of NYMV, we set out to establish a 60 reverse genetics system for recovering recombinant virus from cloned cDNA. Using cDNA 61 fragments generated by PCR from RNA of NYMV-infected Vero cells we constructed a 62 rescue plasmid containing the putative full-length NYMV antigenome. As recently described 63 for reverse genetics systems of Borna disease virus and measles virus (9), the full-length 64 NYMV cDNA was inserted into the vector pBR-Pol-II in which expression of the viral 65 antigenomic RNA is controlled by an RNA polymerase II promoter. For correct in vivo 66 processing of the 5' and 3' termini of plasmid-derived viral RNA molecules, we inserted 67 sequences encoding a NYMV-specific hammerhead and a hepatitis delta virus ribozyme at the 68 5´ and 3´ ends of the NYMV antigenome, respectively. The complete sequence of the rescue 69 plasmid pNYMV is provided as supplementary figure 1. For easy discrimination between 70 plasmid-derived recombinant and authentic NYMV we introduced a silent A to G mutation at 71 position 416 (A416G) of the NYMV antigenome, thereby creating a diagnostic XhoI 72 restriction site (Fig. 1A) . To recover NYMV from cloned cDNA, we co-transfected 293T To determine whether recovery of a GFP-expressing NYMV would likewise be possible, we 86 generated the rescue plasmid pNYMV-GFP (Fig. 1A ). For this, we modified pNYMV by 87 inserting an expression cassette for humanized GFP (hrGFP) between the viral ORF3 and 88 ORF4 genes. To ensure proper expression of the foreign gene, the hrGFP cassette was flanked 89 by copies of the transcriptional start signal from the viral G gene (S G ) and the transcriptional 90 termination signal from the ORF3 gene (T ORF3 ) (Fig. 1A) . The complete sequence of the 91 rescue plasmid pNYMV-GFP is provided as supplementary figure 2. To reconstitute virus, 92 pNYMV-GFP was transfected into 293T cells together with expression plasmids coding for 93 the NYMV proteins N, ORF3 and L. Four days later, GFP-positive cells first were detectable,almost the entire cell culture (Fig. 1C) . 96
To determine whether the various recombinant NYMV variants might exhibit reduced fitness, 97
we infected Vero cells either with authentic NYMV, recombinant NYMV-(A416G) or 98 recombinant NYMV-GFP at an MOI of 0.01. To measure both, cell-associated as well as cell-99 released virus, the cells were scraped into the culture supernatant every 24 hours and the virus 100 was liberated from its host cells by three repeated freeze-thaw cycles. Titration on Vero cells 101 using the 50% tissue culture infective dose (TCID 50 ) assay revealed indistinguishable growth 102 properties of authentic NYMV and recombinant NYMV-(A416G), whereas the GFP-103 expressing NYMV seemed to multiply at slightly reduced rate compared to authentic or 104 recombinant NYMV lacking the foreign gene cassette (Fig. 1D) . 105
We next used the NYMV rescue system to assess the function of two hitherto poorly 106 characterized NYMV proteins. To this end we tried to recover recombinant viruses in which 107 either ORF2 (NYMV-ΔORF2/GFP) or ORF4 (NYMV-ΔORF4/GFP) was replaced by hrGFP. indicating that the product of ORF2 is essential for NYMV propagation. 116
In striking contrast, NYMV-ΔORF4/GFP was successfully recovered under similar 117 experimental conditions. However, propagation of NYMV-ΔORF4/GFP was strongly 118 attenuated, and nearly complete infection of the culture was only achieved by day 28 post 119 plasmid transfection (Fig. 2A) . Interestingly, NYMV-ΔORF4/GFP established a persisting 120 infection in the host cells without inducing any detectable cytopathic effects. Furthermore, 121 NYMV-ΔORF4/GFP seemed to spread only between neighboring cells, indicating impaired 122 ability of the virus to form infectious particles. In line with this hypothesis and in contrast to 123 findings with NYMV-GFP, we were unable to detect infectious virus in the supernatant of the 124 cell culture throughout the course of the rescue experiment (Fig. 2B, left panel, and data not  125 shown). Notably, if the ORF4 product was provided in trans by transiently transfecting 126 plasmid pCA-ORF4 into persistently infected rescue cells, NYMV-ΔORF4/GFP was 127 successfully recovered as evident from the appearance of infectious virus in the culture 128 supernatant (Fig. 2B, right panel) . These results strongly suggested that ORF4 of NYMV 129 plays a key role in viral particle assembly. 130
To support this hypothesis, we performed comparative ultrathin section electron microscopy 131 of 293T cells infected with either NYMV-GFP or NYMV-ΔORF4/GFP and screened for the 132 presence of viral particles. Numerous vesicles seemingly containing enveloped viral particles 133
were present in cells infected with NYMV-GFP for 96 h (Fig. 3A, left panels) . The size of 134 these enveloped particles was approximately 70-100 nm in diameter which is in good 135 agreement with the NYMV size estimate from a recent study (11). Vesicular structures with 136 such content were not detected in uninfected 293T cells (data not shown). Importantly, 293T 137 cells persistently infected with mutant NYMV-ΔORF4/GFP also did not show such particle-138 loaded vesicles (Fig. 3A , right panel), although they contained high levels of viral antigen 139 (Fig. 3B) . Taken together, these observations demonstrate that the ORF4 product is essential 140 for the formation of NYMV particles. 141
We showed here that the genetic manipulation of NYMV is feasible if standard reverse 142 genetics technology is employed that has successfully been used for other negative-strand 143 RNA viruses in the past. We found that NYMV can tolerate the insertion of a foreign gene 144 which will greatly facilitate future experimental work with this virus for which no good 145 antibodies are available at present. We began to use the newly developed reverse genetics 146 technology to investigate the roles of two viral proteins with unclear functions. We found that 147 NYMV lacking the ability to synthesize ORF2 could not be recovered, whereas NYMV 148 lacking ORF4 remained replication-competent and could establish a persisting infection. 
